Abstract
An interferon-induced endoribonuclease, ribonuclease L (RNase L), is implicated in both the molecular mechanism of action of interferon and the fundamental control of RNA stability in mammalian cells. RNase L is catalytically active only after binding to an unusual activator molecule containing a 5′-phosphorylated 2′,5′-linked oligoadenylate (2-5A), in the N-terminal half. Here, we report the crystal structure of the N-terminal ankyrin repeat domain (ANK) of human RNase L complexed with the activator 2-5A. This is the first structural view of an ankyrin repeat structure directly interacting with a nucleic acid, rather than with a protein. The ANK domain folds into eight ankyrin repeat elements and forms an extended curved structure with a concave surface. The 2-5A molecule is accommodated at a concave site and directly interacts with ankyrin repeats 2-4. Interestingly, two structurally equivalent 2-5A binding motifs are found at repeats 2 and 4. The structural basis for 2-5A recognition by ANK is essential for designing stable 2-5As with a high likelihood of activating RNase L.
| Original language | English |
|---|---|
| Pages (from-to) | 3929-3938 |
| Number of pages | 10 |
| Journal | EMBO Journal |
| Volume | 23 |
| Issue number | 20 |
| DOIs | |
| State | Published - 13 Oct 2004 |
| Externally published | Yes |
Keywords
- 2-5A system
- Ankyrin repeat
- Crystal structure
- Drug design
- Interferon